A Phase 1/2 interventional study of ONT01 in Lupus

Recruiting Early Phase 1 NCT07107659

Study Description

A study testing the safety and effectiveness of an experimental drug called ONT01 in people with lupus kidney disease or systemic lupus

Study Details

Registry ID:
NCT07107659
Conditions:
Lupus Nephritis (LN), Lupus Nephritis - WHO Class III, Lupus Nephritis - WHO Class IV, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus, SLE, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (Disorder)
Phase:
Early Phase 1
Target Enrollment:
61 participants
Start Date:
Age Range:
18–999 years
Healthy Volunteers:
No

Study Locations (1 site)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →